Win rate (last 90d)
● AMBER50%
5/10 tenders
Lost tender value
● RED€4.2M
annualised, last 90 days
Novalac Allernova AR alerts
● RED4
new evidence claims tracked
Prescriber Δ vs Jan
● AMBER−9pp
Danone share of prescribing
Spotlight · Novalac Allernova AR
● Priority responseCombined EHF + ARCategory of oneNovalac Allernova AR (United Pharmaceuticals) is an extensively hydrolysed formula with a built-in anti-reflux thickener (carob bean gum), studied in the ALLAR trial for CMA infants with regurgitation. It is currently a category-of-one in EU paediatric allergy nutrition: Aptamil Pepti, Cow & Gate Pepti and Nestlé Althéra are all unthickened EHFs, and reflux is managed by add-on Carobel or feed switch. The convenience claim is driving prescriber traction in DE, FR, ES, BE - and carries a perverse-incentive risk where the AR feature is chosen ahead of confirmed CMA diagnosis.
Tenders won vs Danone
4 of 9
Prescriber traction
+20pp YTD
Markets affected
DE · FR · ES · BE
Response readiness
Brief in draft Q3
Tender win-rate by market
Prescriber share of voice (6mo trend)
Recent tender results
| Tender | Date | Market | Won by | Value | Outcome |
|---|---|---|---|---|---|
| T-DE-2026-04 | 2026-04-12 | DE | Novalac Allernova AR | €1.40M | ● LOSS |
| T-UK-2026-05 | 2026-05-02 | UK | Mead Johnson | €2.10M | ● WIN |
| T-FR-2026-05 | 2026-05-18 | FR | Novalac Allernova AR | €0.98M | ● LOSS |
| T-IT-2026-05 | 2026-05-22 | IT | Nestlé Althera | €1.65M | ● WIN |
| T-ES-2026-06 | 2026-06-01 | ES | Novalac Allernova AR | €0.72M | ● LOSS |
| T-NL-2026-06 | 2026-06-03 | NL | Mead Johnson | €0.54M | ● WIN |
| T-BE-2026-06 | 2026-06-08 | BE | Novalac Allernova AR | €0.48M | ● LOSS |
| T-PL-2026-06 | 2026-06-11 | PL | Bebilon Generic | €0.31M | ● WIN |
| T-SE-2026-06 | 2026-06-14 | SE | Nestlé Althera | €0.62M | ● LOSS |
| T-UK-2026-06 | 2026-06-19 | UK | Novalac Allernova AR | €1.88M | ● WIN |
Live tender monitor
● RED1 hr ago
Portfolio gap: Novalac Allernova AR positioned as category-of-one EHF + anti-reflux thickener. No equivalent SKU in Aptamil Pepti or Cow & Gate Pepti range.
● RED5 hr ago
Novalac Allernova AR won DE tender T-DE-2026-04 (€1.4M).
● AMBER2 days
Prescriber traction for Novalac Allernova AR +4pp month-on-month.
● AMBER4 days
FR: tender notice published, CHU Toulouse, response due 2026-07-22.
● GREEN1 week
UK: NHS Supply Chain framework extended for Aptamil AAF.